Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 11:24AM ET
27.88
Dollar change
+0.10
Percentage change
0.36
%
IndexS&P 500 P/E77.57 EPS (ttm)0.36 Insider Own0.04% Shs Outstand5.65B Perf Week0.80%
Market Cap157.43B Forward P/E10.14 EPS next Y2.75 Insider Trans0.13% Shs Float5.64B Perf Month3.11%
Income2.13B PEG- EPS next Q0.55 Inst Own70.13% Short Float1.27% Perf Quarter-2.55%
Sales58.50B P/S2.69 EPS this Y20.34% Inst Trans0.52% Short Ratio1.65 Perf Half Y-13.15%
Book/sh15.77 P/B1.77 EPS next Y24.12% ROA1.01% Short Interest71.65M Perf Year-30.28%
Cash/sh2.25 P/C12.41 EPS next 5Y-1.20% ROE2.31% 52W Range25.61 - 42.22 Perf YTD-3.16%
Dividend Est.1.71 (6.12%) P/FCF32.85 EPS past 5Y-27.43% ROI1.39% 52W High-33.96% Beta0.60
Dividend TTM1.65 (5.92%) Quick Ratio0.69 Sales past 5Y10.96% Gross Margin48.99% 52W Low8.86% ATR (14)0.52
Dividend Ex-DateJan 25, 2024 Current Ratio0.91 EPS Y/Y TTM-93.20% Oper. Margin6.16% RSI (14)54.89 Volatility1.46% 1.95%
Employees88000 Debt/Eq0.84 Sales Y/Y TTM-41.70% Profit Margin3.65% Recom2.24 Target Price31.37
Option/ShortYes / Yes LT Debt/Eq0.72 EPS Q/Q-168.11% Payout439.41% Rel Volume0.61 Prev Close27.78
Sales Surprise-0.84% EPS Surprise163.21% Sales Q/Q-41.34% EarningsJan 30 BMO Avg Volume43.46M Price27.88
SMA201.78% SMA501.49% SMA200-11.97% Trades Volume8,700,133 Change0.36%
Date Action Analyst Rating Change Price Target Change
Mar-22-24Downgrade Argus Buy → Hold
Feb-23-24Initiated Guggenheim Buy $36
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $32
Oct-20-23Resumed UBS Neutral $36 → $34
Oct-16-23Upgrade Jefferies Hold → Buy $38 → $39
Jul-17-23Reiterated JP Morgan Neutral $45 → $41
Jul-14-23Initiated HSBC Securities Buy $50
Jun-29-23Downgrade Credit Suisse Outperform → Neutral $47 → $40
May-11-23Downgrade Daiwa Securities Outperform → Neutral $38
Mar-06-23Initiated Jefferies Hold $43
Today 10:06AM
Mar-27-24 01:40PM
09:25AM
09:00AM
08:20AM
04:50AM Loading…
04:50AM
Mar-26-24 05:12PM
02:47PM
08:36AM
06:18AM
06:18AM
04:17AM
Mar-25-24 05:45PM
09:48AM
06:47AM
06:25AM Loading…
06:25AM
05:51AM
04:50AM
Mar-24-24 10:42AM
Mar-23-24 06:45AM
05:50AM
05:43AM
04:30AM
Mar-22-24 10:07PM
Mar-21-24 03:30PM
11:38AM
11:31AM
11:06AM
10:35AM
07:30AM
01:43AM Loading…
01:43AM
Mar-20-24 05:51PM
03:38PM
02:32PM
01:26PM
10:34AM
10:00AM
10:00AM
07:49AM
06:22AM
06:15AM
Mar-19-24 05:45PM
12:19PM
11:08AM
10:31AM
04:24AM
Mar-18-24 03:39PM
03:28PM
02:59PM
11:12AM
05:49AM
05:17AM
03:09AM
Mar-17-24 02:49PM
02:36PM
08:50AM
Mar-16-24 05:51AM
Mar-15-24 12:51PM
09:30AM
09:00AM
05:50AM
Mar-14-24 02:16PM
12:26PM
10:30AM
10:27AM
05:25AM
Mar-13-24 05:45PM
09:54AM
08:39AM
04:00AM
Mar-12-24 02:26PM
02:26PM
01:20PM
09:09AM
07:11AM
06:55AM
06:45AM
Mar-11-24 12:44PM
10:33AM
09:45AM
09:28AM
Mar-10-24 07:10PM
02:01PM
09:35AM
08:36AM
06:35AM
Mar-09-24 01:09PM
10:06AM
01:59AM
Mar-08-24 04:38PM
02:41PM
11:15AM
Mar-07-24 07:09PM
09:21AM
Mar-06-24 07:42PM
01:08PM
12:02PM
Mar-05-24 01:54PM
10:00AM
09:13AM
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOURLA ALBERTChairman & CEOFeb 23 '24Option Exercise27.34127,6743,490,607439,748Feb 27 01:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23 '24Option Exercise27.3495,7552,617,942230,920Feb 27 01:46 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23 '24Option Exercise27.3463,8371,745,304218,148Feb 27 01:46 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23 '24Option Exercise27.3429,436804,780123,073Feb 27 01:46 PM
McDermott MichaelExecutive Vice PresidentFeb 23 '24Option Exercise27.3412,412339,34495,408Feb 27 01:47 PM
SAHNI PAYALExecutive Vice PresidentFeb 23 '24Option Exercise27.3411,527315,14834,604Feb 27 01:46 PM
DAMICO JENNIFER B.SVP & ControllerFeb 23 '24Option Exercise27.349,752266,62019,228Feb 27 01:46 PM
BOSHOFF CHRISTOFFELExecutive Vice PresidentFeb 23 '24Option Exercise27.349,752266,620148,703Feb 27 01:44 PM
Gottlieb ScottDirectorDec 15 '23Buy26.473,00079,4019,000Dec 19 09:31 AM
Gottlieb ScottDirectorMay 08 '23Buy38.581,00038,5806,000May 09 04:17 PM
Gottlieb ScottDirectorMay 05 '23Buy38.421,00038,4255,000May 09 04:17 PM